Vascular endothelial growth factor (VEGF) is a potent angiogenic factor with a unique specificity for vascular endothelial cells. In addition to its role in vasculogenesis and embryonic angiogenesis, VEGF is implicated in pathologic neovascularization associated with tumors and diabetic retinopathy.
A Modular, Hydroxyapatite-Binding Version of Vascular Endothelial Growth Factor
โ Scribed by Jae Sung Lee; Amy J. Wagoner Johnson; William L. Murphy
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 643 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0935-9648
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Vascular endothelial growth factor (VEGF) was identified as a heparin-binding polypeptide mitogen with a target cell specificity restricted to vascular endothelial cells. Molecular cloning reveals the existence of four species of VEGF having 121, 165, 189, and 206 amino acids. These have strikingly
## Abstract ## Background and Methods. VEGF proteins and their receptors are involved in tumor vessel neoformation. The third VEGF receptor, VEGFR3 (fltโ4) is important during both blood vessel development and lymphatic vessel formation. Because HNSCC preferentially metastasizes to regional lymph
The opinions and assertions contained herein are the expressed views of the authors and are not to be construed as official or reflecting the views of the Departments of the Army or Defense.